Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by David P. Steensma

1-50 of 476 results

View this query on the Wikidata Query Service
MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

scientific article published on 25 July 2006
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes

scientific article published on April 30, 2015
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients

scientific article
Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes

scientific article
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials

scientific article
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

scientific article
The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

scientific article published on 28 April 2005
Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial

scientific article published on 15 June 2009
Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation

scientific article
A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia

scientific article
The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates

scientific article
SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value

scientific article
The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis

scientific article published on 27 February 2009
Recent developments in myelodysplastic syndromes.

scientific article
JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained

scientific article published on 01 June 2006
Mutations in the chromatin-associated protein ATRX.

scientific article published in June 2008
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

scientific article published on April 2016
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015
The myelodysplastic syndrome(s): a perspective and review highlighting current controversies

scientific article
Niche-based screening identifies small-molecule inhibitors of leukemia stem cells

scientific article
The myelodysplastic syndromes: diagnosis and treatment

scientific article
Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria

scientific article
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions

scientific article published in December 2016
Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data

scientific article (publication date: 8 July 2009)
The well-being and personal wellness promotion strategies of medical oncologists in the North Central Cancer Treatment Group

scientific article
Deferasirox reduces serum ferritin and labile plasma iron in RBC transfusion-dependent patients with myelodysplastic syndrome

scientific article published on 30 April 2012
Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms.

scientific article published in April 2018
Vascular and Metabolic Implications of Novel Targeted Cancer Therapies: Focus on Kinase Inhibitors

scientific article published on September 2015
Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia

scientific article
Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial

scientific article
JAK2 V617F in myeloid disorders: molecular diagnostic techniques and their clinical utility: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology

scientific article published on September 2006
Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies

scientific article
A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets

scientific article published on 27 November 2013
Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodysplastic syndrome

scientific article published on 31 October 2002
Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience

scientific article
High cancer drug prices in the United States: reasons and proposed solutions

scientific article published on 6 May 2014
Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study.

scientific article published on October 2009
Caring for the whole patient: the science of psychosocial care

scientific article published on 12 March 2012
Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia

scientific article published on July 13, 2015
Health care utilization and end-of-life care for older patients with acute myeloid leukemia

scientific article published on 29 April 2015
Acquired somatic ATRX mutations in myelodysplastic syndrome associated with α thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations

scientific article published on October 30, 2003
Anemia in the elderly: how should we define it, when does it matter, and what can be done?

scientific article published on August 2007
A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML)

scientific article
Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study

scientific article published in March 2002
Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large internet-based survey

scientific article published on 4 December 2007
Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides.

scientific article published on 14 October 2015
Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts

scientific article published in August 2008
International working group for myelofibrosis research and treatment response assessment and long-term follow-up of 50 myelofibrosis patients treated with thalidomide-prednisone based regimens

scientific article published in January 2011
Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia

scientific article published in May 2002
Dysplasia Has A Differential Diagnosis: Distinguishing Genuine Myelodysplastic Syndromes (MDS) From Mimics, Imitators, Copycats and Impostors

scientific article published on December 1, 2012

Paulina is supported by:

About Paulina

Help